Clinical trials
Completed Migraine Disorders trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Chengdu University of Traditional Chinese Medicine | 2 |
| H. Lundbeck A/S | 2 |
| AbbVie | 1 |
| Allergan | 1 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| Dongzhimen Hospital, Beijing | 1 |
| Eli Lilly and Company | 1 |
| Haiyan Wang | 1 |
| Jiangsu Kanion Pharmaceutical Co., Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Migraine Disorders | 25 |
| Foramen Ovale, Patent | 3 |
| Headache | 2 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Cerebral Infarction | 1 |
| Headache Disorders, Secondary | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.